ERBB2 and breast carcinoma: On the molecular level, breast cancer is a heterogeneous disease and generally divided into various types according to the expression status of estrogen receptors, progesterone, and ErbB2.[51] Cancer progression is generally associated with alterations in cellular responses to both chemical and mechanical signals.